CLVS Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report) 		Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2022-04-27 2021 Patrick J. Mahaffy President and Chief Executive Officer 738,687 0 0 0 22,246 2,639,083
2022-04-27 2020 Patrick J. Mahaffy President and Chief Executive Officer 720,670 491,858 0 0 22,046 3,229,519
2022-04-27 2019 Patrick J. Mahaffy President and Chief Executive Officer 718,640 454,024 0 0 21,846 6,907,470
2022-04-27 2021 Daniel W. Muehl EVP and Chief Financial Officer 481,818 181,563 504,630 0 22,670 1,190,681
2022-04-27 2020 Daniel W. Muehl EVP and Chief Financial Officer 468,851 229,158 613,460 0 21,969 1,333,438
2022-04-27 2019 Daniel W. Muehl EVP and Chief Financial Officer 453,683 216,359 2,317,037 0 21,410 3,579,671
2022-04-27 2021 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 492,940 185,754 504,630 0 28,368 1,211,692
2022-04-27 2020 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 479,674 234,448 613,460 0 27,820 1,355,402
2022-04-27 2019 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 464,692 221,354 1,544,691 0 27,368 2,638,893
2022-04-27 2021 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 535,630 201,867 504,630 0 0 1,242,127
2022-04-27 2020 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 518,294 254,784 613,460 0 0 1,386,538
2022-04-27 2019 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 504,656 240,553 1,544,691 0 14,822 2,685,510
2022-04-27 2021 Paul E. Gross EVP and General Counsel 486,260 183,237 504,630 0 22,385 1,196,512
2022-04-27 2020 Paul E. Gross EVP and General Counsel 473,174 231,272 613,460 0 21,704 1,339,610
2022-04-27 2019 Paul E. Gross EVP and General Counsel 457,866 218,354 2,317,037 0 21,159 3,585,598
2021-04-28 2020 Paul E. Gross EVP and General Counsel 473,174 231,272 613,460 0 21,704 1,339,610
2021-04-28 2018 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 486,505 195,720 642,730 0 19,816 1,819,011
2021-04-28 2019 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 504,656 240,553 1,544,691 0 14,822 2,685,510
2021-04-28 2020 Lindsey Rolfe EVP of Clinical Development and Pharmacovigilance and 518,294 254,784 613,460 0 0 1,386,538
2021-04-28 2018 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 448,060 180,098 642,730 0 18,892 1,764,020
2021-04-28 2019 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 464,692 221,354 1,544,691 0 27,368 2,638,893
2021-04-28 2019 Daniel W. Muehl EVP and Chief Financial Officer 453,683 216,359 2,317,037 0 21,410 3,579,671
2021-04-28 2020 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 479,674 234,448 613,460 0 27,820 1,355,402
2021-04-28 2018 Daniel W. Muehl EVP and Chief Financial Officer 424,000 156,169 525,870 0 15,530 1,509,583
2021-04-28 2020 Daniel W. Muehl EVP and Chief Financial Officer 468,851 229,158 613,460 0 21,969 1,333,438
2021-04-28 2018 Patrick J. Mahaffy President and Chief Executive Officer 688,583 389,928 0 0 15,423 6,267,458
2021-04-28 2019 Paul E. Gross EVP and General Counsel 457,866 218,354 2,317,037 0 21,159 3,585,598
2021-04-28 2019 Patrick J. Mahaffy President and Chief Executive Officer 718,640 454,024 0 0 21,846 6,907,470
2021-04-28 2020 Patrick J. Mahaffy President and Chief Executive Officer 720,670 491,858 0 0 22,046 3,229,519
2020-04-24 2019 Patrick J. Mahaffy President and Chief Executive Officer 718,640 454,024 0 0 21,846 6,907,470
2020-04-24 2019 Paul E. Gross 457,866 218,354 2,317,037 0 21,159 3,585,598
2020-04-24 2017 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 463,838 243,225 683,100 0 27,830 2,429,681
2020-04-24 2018 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 486,505 195,720 642,730 0 19,816 1,819,011
2020-04-24 2019 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 504,656 240,553 1,544,691 0 14,822 2,685,510
2020-04-24 2017 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 435,003 226,216 683,100 0 27,872 2,383,879
2020-04-24 2018 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 448,060 180,098 642,730 0 18,892 1,764,020
2020-04-24 2019 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 464,692 221,354 1,544,691 0 27,368 2,638,893
2020-04-24 2017 Daniel W. Muehl EVP and Chief Financial Officer 367,500 222,500 512,325 0 15,376 1,876,467
2020-04-24 2018 Daniel W. Muehl EVP and Chief Financial Officer 424,000 156,169 525,870 0 15,530 1,509,583
2020-04-24 2019 Daniel W. Muehl EVP and Chief Financial Officer 453,683 216,359 2,317,037 0 21,410 3,579,671
2020-04-24 2017 Patrick J. Mahaffy President and Chief Executive Officer 636,083 485,975 0 0 16,757 8,726,475
2020-04-24 2018 Patrick J. Mahaffy President and Chief Executive Officer 688,583 389,928 0 0 15,423 6,267,458
2019-04-26 2017 Patrick J. Mahaffy President and Chief Executive Officer 636,083 485,975 0 0 16,757 8,726,475
2019-04-26 2017 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 435,003 226,216 683,100 0 27,872 2,383,879
2019-04-26 2016 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 422,300 286,443 1,214,400 0 26,423 1,949,566
2019-04-26 2018 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 486,505 195,720 642,730 0 19,816 1,819,011
2019-04-26 2017 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 463,838 243,225 683,100 0 27,830 2,429,681
2019-04-26 2016 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 427,500 293,625 2,226,400 0 3,796 2,951,321
2019-04-26 2018 C. Dale Hooks Former Senior VP and Chief Commercial Officer 347,533 0 525,870 0 302,385 1,563,802
2019-04-26 2017 C. Dale Hooks Former Senior VP and Chief Commercial Officer 393,333 284,000 512,325 0 16,322 1,964,746
2019-04-26 2016 C. Dale Hooks Former Senior VP and Chief Commercial Officer 356,250 216,000 315,947 0 13,019 1,809,288
2019-04-26 2018 Daniel W. Muehl Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer 424,000 156,169 525,870 0 15,530 1,509,583
2019-04-26 2017 Daniel W. Muehl Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer 367,500 222,500 512,325 0 15,376 1,876,467
2019-04-26 2016 Daniel W. Muehl Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer 308,879 170,799 247,313 0 12,679 1,564,469
2019-04-26 2016 Patrick J. Mahaffy President and Chief Executive Officer 223,563 552,338 0 0 12,718 788,619
2019-04-26 2018 Patrick J. Mahaffy President and Chief Executive Officer 688,583 389,928 0 0 15,423 6,267,458
2019-04-26 2018 Gillian C. Ivers-Read EVP and Chief Regulatory Officer 448,060 180,098 642,730 0 18,892 1,764,020
2018-04-27 2015 Patrick J. Mahaffy President and Chief Executive Officer 563,750 0 0 0 15,522 5,670,992
2018-04-27 2017 C. Dale Hooks Senior VP and Chief 393,333 284,000 512,325 0 16,322 1,964,746
2018-04-27 2016 C. Dale Hooks Senior VP and Chief 356,250 216,000 315,947 0 13,019 1,809,288
2018-04-27 2017 Daniel W. Muehl Senior VP of Finance, 367,500 222,500 512,325 0 15,376 1,876,467
2018-04-27 2016 Daniel W. Muehl Senior VP of Finance, 308,879 170,799 247,313 0 12,679 1,564,469
2018-04-27 2017 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 435,003 226,216 683,100 0 27,872 2,383,879
2018-04-27 2016 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 422,300 286,443 1,214,400 0 26,423 1,949,566
2018-04-27 2015 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 410,000 61,182 0 0 26,423 2,279,707
2018-04-27 2017 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 463,838 243,225 683,100 0 27,830 2,429,681
2018-04-27 2016 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 427,500 293,625 2,226,400 0 3,796 2,951,321
2018-04-27 2016 Patrick J. Mahaffy President and Chief Executive Officer 223,563 552,338 0 0 12,718 788,619
2018-04-27 2015 Lindsey Rolfe EVP of Clinical and Pre-Clinical Development and 350,409 57,915 0 0 71,815 3,070,839
2018-04-27 2017 Patrick J. Mahaffy President and Chief Executive Officer 636,083 485,975 0 0 16,757 8,726,475
2017-04-26 2016 Daniel W. Muehl 308,879 170,799 247,313 0 12,679 1,564,469
2017-04-26 2016 Patrick J. Mahaffy President and Chief Executive Officer 223,563 552,338 0 0 12,718 788,619
2017-04-26 2015 Patrick J. Mahaffy President and Chief Executive Officer 563,750 0 0 0 15,522 5,670,992
2017-04-26 2014 Patrick J. Mahaffy President and Chief Executive Officer 544,167 357,500 0 0 15,146 10,123,033
2017-04-26 2016 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 422,300 286,443 1,214,400 0 26,423 1,949,566
2017-04-26 2015 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 410,000 61,182 0 0 26,423 2,279,707
2017-04-26 2014 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 395,217 180,000 0 0 26,093 3,823,487
2017-04-26 2016 Lindsey Rolfe EVP of Clinical and Pre-Clinical 427,500 293,625 2,226,400 0 3,796 2,951,321
2017-04-26 2015 Lindsey Rolfe EVP of Clinical and Pre-Clinical 350,409 57,915 0 0 71,815 3,070,839
2017-04-26 2016 C. Dale Hooks 356,250 216,000 315,947 0 13,019 1,809,288
2017-04-26 2016 Erle T. Mast Former EVP and Chief Financial Officer 135,952 0 0 0 6,382 142,334
2017-04-26 2015 Erle T. Mast Former EVP and Chief Financial Officer 410,000 61,182 0 0 15,522 2,268,806
2017-04-26 2014 Erle T. Mast Former EVP and Chief Financial Officer 395,217 180,000 0 0 15,146 3,812,540
2016-04-27 2014 Steven L. Hoerter EVP and Chief Commercial Officer 337,417 136,000 0 0 13,265 3,478,704
2016-04-27 2015 Andrew R. Allen Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 324,578 0 0 0 13,121 4,982,170
2016-04-27 2014 Andrew R. Allen Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 441,350 202,500 0 0 15,474 3,881,501
2016-04-27 2014 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 395,217 180,000 0 0 26,093 3,823,487
2016-04-27 2013 Andrew R. Allen Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 396,167 238,860 0 0 15,485 1,668,945
2016-04-27 2015 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 410,000 61,182 0 0 26,423 2,279,707
2016-04-27 2013 Erle T. Mast EVP, Chief Financial Officer 369,500 222,780 0 0 15,255 1,625,968
2016-04-27 2014 Erle T. Mast EVP, Chief Financial Officer 395,217 180,000 0 0 15,146 3,812,540
2016-04-27 2015 Erle T. Mast EVP, Chief Financial Officer 410,000 61,182 0 0 15,522 2,268,806
2016-04-27 2013 Patrick J. Mahaffy President and Chief Executive Officer 512,500 412,000 0 0 15,255 3,655,575
2016-04-27 2014 Patrick J. Mahaffy President and Chief Executive Officer 544,167 357,500 0 0 15,146 10,123,033
2016-04-27 2015 Patrick J. Mahaffy President and Chief Executive Officer 563,750 0 0 0 15,522 5,670,992
2016-04-27 2013 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 369,500 222,780 0 0 26,142 1,636,855
2016-04-27 2015 Lindsey Rolfe 350,409 57,915 0 0 71,815 3,070,839
2016-04-27 2015 Steven L. Hoerter EVP and Chief Commercial Officer 356,667 0 0 0 14,254 2,153,023
2016-04-27 2013 Steven L. Hoerter EVP and Chief Commercial Officer 322,917 178,475 0 0 13,242 1,329,380
2015-04-30 2014 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 441,350 202,500 0 0 15,474 3,881,501
2015-04-30 2012 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 358,750 115,360 0 0 24,383 1,282,928
2015-04-30 2013 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 369,500 222,780 0 0 26,142 1,636,855
2015-04-30 2013 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 396,167 238,860 0 0 15,485 1,668,945
2015-04-30 2012 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 384,583 123,680 0 0 15,885 1,308,583
2015-04-30 2014 Steven L. Hoerter EVP and Chief Commercial Officer 337,417 136,000 0 0 13,265 3,478,704
2015-04-30 2013 Steven L. Hoerter EVP and Chief Commercial Officer 322,917 178,475 0 0 13,242 1,329,380
2015-04-30 2014 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 395,217 180,000 0 0 26,093 3,823,487
2015-04-30 2013 Erle T. Mast EVP, Chief Financial Officer 369,500 222,780 0 0 15,255 1,625,968
2015-04-30 2014 Erle T. Mast EVP, Chief Financial Officer 395,217 180,000 0 0 15,146 3,812,540
2015-04-30 2013 Patrick J. Mahaffy President and Chief Executive Officer 512,500 412,000 0 0 15,255 3,655,575
2015-04-30 2014 Patrick J. Mahaffy President and Chief Executive Officer 544,167 357,500 0 0 15,146 10,123,033
2014-04-30 2013 Erle T. Mast EVP, Chief Financial Officer 369,500 222,780 0 0 15,255 1,625,968
2014-04-30 2011 Steven L. Hoerter Senior Vice President of Commercial 106,910 86,270 0 0 59,404 865,185
2014-04-30 2012 Steven L. Hoerter Senior Vice President of Commercial 314,167 138,200 0 0 14,434 1,408,123
2014-04-30 2013 Steven L. Hoerter Senior Vice President of Commercial 322,917 178,475 0 0 13,242 1,329,380
2014-04-30 2013 Andrew R. Allen 396,167 238,860 0 0 15,485 1,668,945
2014-04-30 2013 Gillian C. Ivers-Read 369,500 222,780 0 0 26,142 1,636,855
2014-04-30 2011 Erle T. Mast EVP, Chief Financial Officer 345,833 140,000 0 0 14,473 649,967
2014-04-30 2012 Erle T. Mast EVP, Chief Financial Officer 358,750 115,360 0 0 15,310 1,273,855
2014-04-30 2011 Patrick J. Mahaffy President and Chief Executive Officer 437,500 225,000 0 0 13,873 1,125,360
2014-04-30 2012 Patrick J. Mahaffy President and Chief Executive Officer 491,667 200,000 0 0 14,448 3,059,420
2014-04-30 2013 Patrick J. Mahaffy President and Chief Executive Officer 512,500 412,000 0 0 15,255 3,655,575
2013-04-29 2011 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 345,833 140,000 0 0 24,182 659,676
2013-04-29 2010 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 325,000 52,000 0 0 19,768 396,769
2013-04-29 2010 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 325,000 52,000 0 0 13,332 390,332
2013-04-29 2012 Steven L. Hoerter Senior Vice President, Commercial 314,167 138,200 0 0 14,434 1,408,123
2013-04-29 2011 Steven L. Hoerter Senior Vice President, Commercial 106,910 86,270 0 0 59,404 865,185
2013-04-29 2012 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 384,583 123,680 0 0 15,885 1,308,583
2013-04-29 2011 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 366,667 150,000 0 0 15,685 682,012
2013-04-29 2010 Patrick J. Mahaffy President and Chief Executive Officer 375,000 75,000 0 0 12,554 462,554
2013-04-29 2012 Erle T. Mast EVP, Chief Financial Officer 358,750 115,360 0 0 15,310 1,273,855
2013-04-29 2011 Patrick J. Mahaffy President and Chief Executive Officer 437,500 225,000 0 0 13,873 1,125,360
2013-04-29 2011 Erle T. Mast EVP, Chief Financial Officer 345,833 140,000 0 0 14,473 649,967
2013-04-29 2012 Patrick J. Mahaffy President and Chief Executive Officer 491,667 200,000 0 0 14,448 3,059,420
2013-04-29 2010 Erle T. Mast EVP, Chief Financial Officer 325,000 52,000 0 0 12,562 389,562
2013-04-29 2012 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 358,750 115,360 0 0 24,383 1,282,928
2012-04-27 2010 Erle T. Mast EVP, Chief Financial Officer 325,000 52,000 0 0 12,562 389,562
2012-04-27 2011 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 345,833 140,000 0 0 24,182 659,676
2012-04-27 2010 Gillian C. Ivers-Read EVP of Technical Operations and Chief Regulatory Officer 325,000 52,000 0 0 19,768 396,769
2012-04-27 2011 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 366,667 150,000 0 0 15,685 682,012
2012-04-27 2010 Andrew R. Allen EVP of Clinical and Pre-Clinical Development and Chief Medical Officer 325,000 52,000 0 0 13,332 390,332
2012-04-27 2011 Steven L. Hoerter Senior Vice President of Commercial 106,910 86,270 0 0 59,404 865,185
2012-04-27 2011 Patrick J. Mahaffy President and Chief Executive Officer 437,500 225,000 0 0 13,873 1,125,360
2012-04-27 2010 Patrick J. Mahaffy President and Chief Executive Officer 375,000 75,000 0 0 12,554 462,554
2012-04-27 2011 Erle T. Mast EVP, Chief Financial Officer 345,833 140,000 0 0 14,473 649,967

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.